Lunt Mark, Symmons Deborah P M, Silman Alan J
University of Manchester Medical School, UK.
Arthritis Rheum. 2005 Aug;52(8):2277-83. doi: 10.1002/art.21203.
The American College of Rheumatology (ACR) 1987 criteria for rheumatoid arthritis (RA) can be applied in 2 formats, a standard "x/y" list and a decision tree. This study evaluated the performance of the decision tree compared with the list approach in the ascertainment of RA in subjects with new-onset inflammatory polyarthritis (IP) over the first 5 years of observation. Moreover, the use of clinical surrogates to substitute for missing rheumatoid factor (RF) and radiologic erosion data was assessed for validity and for its influence on the resulting RA prevalence estimates.
In this population-based prospective study, 848 subjects with new-onset IP were interviewed and examined at baseline, with followup at 1, 2, 3, and 5 years. RF and erosion status were determined at prespecified time points. The list criteria were applied cumulatively, while the decision tree was applied cross-sectionally using either data surrogates or the actual reported data. RA prevalence in the 848 subjects and agreement in classification between the 2 methods was assessed at each time point. The influence of using clinical surrogates on RA prevalence estimates at 5 years and the agreement between surrogate and real results were also analyzed.
At baseline, RA prevalence was higher using the decision tree compared with the list approach (63% versus 47%; P = 0.0001); by 5 years of followup, RA estimates were approximately equal (69% versus 72%) and agreement between the approaches was good (kappa = 0.67). The use of surrogates had little influence on RA prevalence at 5 years, although substitution of metacarpophalangeal joint swelling for erosion produced a higher RA prevalence estimate (78% versus 70%). Although there was only weak agreement between surrogate and real data, the use of the surrogate data provided good to very good agreement between the approaches in categorizing subjects as RA positive (kappa = 0.61-0.72).
Over 5 years, the 2 formats of the ACR criteria for RA performed similarly, with no important differences between them. The use of surrogates for missing radiologic and serologic data did not have any major influence on disease classification. Although the RA criteria were not originally derived from subjects with early disease in a population setting, this study shows that the use of the decision tree approach with the option of substituting clinical surrogates for missing laboratory data is an appropriate alternative to the conventional list approach.
美国风湿病学会(ACR)1987年类风湿关节炎(RA)标准有两种应用形式,一种是标准的“x/y”列表形式,另一种是决策树形式。本研究评估了在观察的前5年中,决策树形式与列表形式在新发炎性多关节炎(IP)患者中确定RA的性能。此外,还评估了使用临床替代指标替代缺失的类风湿因子(RF)和放射学侵蚀数据的有效性及其对所得RA患病率估计值的影响。
在这项基于人群的前瞻性研究中,对848例新发IP患者在基线时进行了访谈和检查,并在第1、2、3和5年进行随访。在预先设定的时间点确定RF和侵蚀状态。列表标准是累积应用的,而决策树是使用数据替代指标或实际报告的数据进行横断面应用的。在每个时间点评估这848例患者的RA患病率以及两种方法在分类上的一致性。还分析了使用临床替代指标对5年时RA患病率估计值的影响以及替代指标与实际结果之间的一致性。
在基线时,与列表形式相比,决策树形式得出的RA患病率更高(63%对47%;P = 0.0001);到随访5年时,RA患病率估计值大致相等(69%对72%),且两种方法之间的一致性良好(kappa = 0.67)。使用替代指标对5年时的RA患病率影响不大,尽管用掌指关节肿胀替代侵蚀会使RA患病率估计值更高(78%对70%)。尽管替代指标与实际数据之间的一致性较弱,但使用替代指标数据在将患者分类为RA阳性方面,两种方法之间的一致性良好至极优(kappa = 0.61 - 0.72)。
在5年期间,ACR的RA标准的两种形式表现相似,两者之间没有重要差异。使用替代指标替代缺失的放射学和血清学数据对疾病分类没有任何重大影响。尽管RA标准最初并非源自人群中早期疾病的患者,但本研究表明,使用决策树方法并可选择用临床替代指标替代缺失的实验室数据是常规列表方法的一种合适替代方法。